Loading company…
ReproNovo develops therapies for infertility and other reproductive health conditions.
Founded in 2021 and based in Lausanne, Switzerland, ReproNovo develops therapies for reproductive medicine and women's health. Its pipeline addresses male and female infertility and conditions such as adenomyosis. In May 2025, the company raised EUR 57 million in Series A funding co-led by Jeito Capital, AXA IM Alts, and M Ventures, with participation from Ysios Capital Partners and ALSA Ventures. The funding will support pipeline development and market expansion.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in